Literature DB >> 32048122

Combating drug shortages in China: surveillance warning and practice standardization.

Yin Shi1,2,3, Ping Yang1,2,3, Xiangping Li1,2,3, Jinfeng Lv1,2,3, Tao Yin1,2,3, Zhicheng Gong1,2,3, Shusen Sun4,5,6,7, Boting Zhou8,9,10.   

Abstract

Like other countries, China has been experiencing drug shortages during the past years, including drugs on the National Essential Medicine List and emergency drugs. Drug shortages have raised public concerns in China and have severe impacts on all stakeholders in the supply chain, especially patients and hospitals. Recently, Chinese governments have ramped up several measures to ensure a steady supply of essential and first-aid drugs. In this commentary, we share our experiences of addressing drug shortages at Hunan Province, central China. We focus on the establishment of a provincial drug shortage monitoring center, and the Center's efforts to standardize practices on the management of drug shortages and identify therapeutic alternatives for drugs in short supply based on international best practices.

Entities:  

Keywords:  China; Drug shortages; Early warning; Practice standardization; Surveillance

Mesh:

Substances:

Year:  2020        PMID: 32048122     DOI: 10.1007/s11096-020-00987-5

Source DB:  PubMed          Journal:  Int J Clin Pharm


  1 in total

Review 1.  Providing pharmacy services during the coronavirus pandemic.

Authors:  Shao Liu; Ping Luo; Mimi Tang; Qin Hu; Joseph P Polidoro; Shusen Sun; Zhicheng Gong
Journal:  Int J Clin Pharm       Date:  2020-03-28
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.